Monolitum (Lansoprazole)

Lansoprazole blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells in the stomach. By irreversibly inhibiting this pump, it prevents the final step of acid secretion, leading to a sustained reduction in gastric acidity and providing an environment that supports mucosal healing.

The specific dose and dosing schedule of Monolitum are determined by the prescribing healthcare professional based on the individual’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Lansoprazole is classified as pregnancy category B, indicating that animal studies have not shown risk to the fetus and there are no adequate human studies. It may be used during pregnancy if the potential benefit justifies the risk. Limited data are available for breastfeeding; the decision should be made in consultation with a healthcare provider.

To place an order, visit the product page on gnhindia.com, submit an enquiry with the required quantity, and provide institutional or trade credentials. GNH India’s team will verify eligibility, then respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation for hospitals, pharmacies or procurement agencies.

Monolitum (lansoprazole) belongs to the same class as omeprazole, esomeprazole, pantoprazole and rabeprazole. All reduce gastric acid by inhibiting the proton pump, but pharmacokinetic profiles differ; lansoprazole has a rapid onset and may have fewer drug‑interaction concerns with certain antifungals compared with omeprazole. Choice of agent depends on clinical response, drug‑interaction profile and physician preference.

Monolitum should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat and direct sunlight. Do not store in the bathroom or near a kitchen sink where humidity is high.

Monolitum is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistency in timing relative to meals helps maintain steady drug levels. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious but rare risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels leading to muscle cramps or cardiac arrhythmias, and increased risk of bone fractures with long‑term use. Patients should report any unusual symptoms such as rash, persistent diarrhoea, muscle weakness, or unexplained fractures to their clinician promptly.

Monolitum is contraindicated in patients with known hypersensitivity to lansoprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of osteoporosis or low magnesium levels. The prescriber will assess suitability on an individual basis.